Haemonetics (HAE) Current Deferred Tax Assets (2010 - 2015)

Haemonetics' Current Deferred Tax Assets history runs 6 years deep, the most recent figure standing at $12.0 million for Q4 2015.

• On a quarterly basis, Current Deferred Tax Assets fell 25.83% year-over-year to $12.0 million in Q4 2015; TTM through Dec 2015 was $12.0 million, a 25.83% decrease from a year earlier, with the FY2015 full-year figure at $12.6 million, down 10.86% from the prior year.
• Current Deferred Tax Assets held at $12.0 million in Q4 2015 per HAE's latest filing, from $12.0 million in the prior quarter.
• Across five years, Current Deferred Tax Assets topped out at $16.2 million in Q4 2014 and bottomed at $9.5 million in Q4 2011.
• The 5-year median for Current Deferred Tax Assets is $12.6 million (2015), against an average of $12.3 million.
• Across the five-year window, Current Deferred Tax Assets fell 29.47% in 2011 and soared 42.6% in 2013, its largest moves.
• Year by year, Current Deferred Tax Assets stood at $9.5 million in 2011, then rose by 13.91% to $10.8 million in 2012, then soared by 31.19% to $14.2 million in 2013, then grew by 14.06% to $16.2 million in 2014, then dropped by 25.83% to $12.0 million in 2015.
• Per Business Quant, the three latest HAE Current Deferred Tax Assets figures stand at $12.0 million (Q4 2015), $12.0 million (Q3 2015), and $12.7 million (Q2 2015).